Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells

Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells

Background Specific immune response is a hallmark of cancer immunotherapy and shared tumor-associated antigens (TAAs) are important targets. Recent advances using combined cellular therapy against multiple TAAs renewed the interest in this class of antigens. Our study aims to determine the role of T...

Full description

Bibliographic Details
Main Authors: Alexander Quaas, Hans Anton Schlößer, Michael von Bergwelt-Baildon, Martin Thelen, Birgit Gathof, Axel M Hillmer, Christiane Bruns, Diandra Keller, Jonas Lehmann, Kerstin Wennhold, Hendrik Weitz, Eugen Bauer, Monika Brüggemann, Michaela Kotrova, Christoph Mallmann, Seung-Hun Chon, Maria Alejandra Garcia-Marquez
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/12/e005200.full

Internet

https://jitc.bmj.com/content/10/12/e005200.full

Similar Items